Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-25 @ 8:44 PM
NCT ID:
NCT03924869
Pre Assignment Details:
Of 737 participants screened, 448 were randomized 1:1 to receive either stereotactic body radiotherapy (SBRT) plus pembrolizumab or SBRT plus placebo.
Recruitment Details:
Male and female participants at least 18 years of age with unresected Stage I or II (limited Stage IIB N0, M0) Non-Small Cell Lung Cancer (NSCLC) who had received no prior anticancer therapy for their present lung cancer were recruited.
Study:
NCT03924869
Study Brief:
Results Section:
NCT03924869